This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.
If three sticking points aren’t unstuck soon, older Americans won’t benefit much by the 1,000+ medical devices that, as of 2025, are both equipped with AI and cleared by the FDA.
A new generation of AI-native researchers is leading the way in the war on cancer. This next crop of scientists is AI-native, interdisciplinary—and comfortable challenging assumptions.
The roots of medicine are in the promotion of human welfare, aka humanitarianism. Healthcare AI can either degrade or reinforce this heritage. Who picks the path?
New ACC/AHA recommendations encourage clinicians to take a proactive approach when managing patients with elevated or high blood pressure. The inclusion of renal denervation in this document represents clear progress for a relatively new technology.
Researchers from Brigham and Women's Hospital and Harvard Medical School compared 89 generic drugs sold by Mark Cuban Cost Plus Drug Company (MCCPDC) to what Medicare paid for the same drugs in 2020.
While a vast majority of heart transplants in the United States are successful, unplanned hospitalizations after the procedures are still incredibly common.
When the ongoing contrast media shortage first started impacting health systems, one group in Ohio pledged not to delay a single procedure in its cath labs.
The court case stems from HHS’ 2018 final rule establishing separate reimbursement rates for hospitals that serve low-income or rural populations through the 340B program and all other hospitals.